Apoptosis Modulation as a Promising Target for Treatment of Systemic Sclerosis PDF Print E-mail
Thursday, 01 March 2012 16:35
St´ephane Chabaud and V´eronique J. Moulin
Received 1 June 2011; Revised 6 July 2011; Accepted 6 July 2011

Systemic sclerosis (scleroderma, SSc) is a heterogeneous disease which develops into three forms: limited, intermediate, and diffuse. The limited form only affects skin of the limbs. In addition to cutaneous disorders, the diffuse one also affects internal organs such as lungs, heart, and kidneys. After a debilitating phase, the most severe form leads to death. This disease is characterized by a strong autoimmune reaction, although it is not clear whether this is a consequence of the disease or a causal factor. Nevertheless, autoantibodies, principally raised against nuclear epitopes, are used like prognostic markers.

In the United States, the disease strikes more African American people and females than Caucasians and males. Besides, the disease appears more prematurely in the African American group and hits them more severely than the Caucasians. The mortality rate for SSc in the group of women has increased by seventy percent over the last twenty years without convincing explanations. The cost of the medical care associated with this disease was estimated at more than $20,000 per patient per year in Canada. The disease is particularly devastating because it strikes people during the most productive period of their professional life.

The causes of SSc are not clearly identified. Genetic factors could not be excluded, but environmental influence seems to be more important. Notably, chronic exposition to chemicals, such as organic solvents and silicone, viral infection by cytomegalovirus (CMV), a member of herpesviruses family, and microchimerism, could all play a role in the disease.

It is thought that SSc begins with vasculopathies through massive endothelial cells death that would lead to obliteration of small arteries and arterioles. It is however unclear if autoantibodies are produced before vascular damages and/or in response to it. Subsequently, cell-to-cell communications are substantially altered, notably by cytokine and growth factor secretion dysregulation. The consequence of these biological changes is an excessive extracellular matrix (ECM) deposition, fibrosis, in tissues followed by their loss of function. SSc varies during the progression of the disease, showing noteworthy changes in fibroblasts phenotype. At the early stage of the disease, cells respond to TGFβ, but become totally insensitive at the late stage for the most affected patients, explaining why treatments targeting this cytokine remain mostly ineffective.

Over the last decades, various models had been used to study SSc. Some animals develop a disease similar to this pathology such as UCD-200 chicken, Tsk-1 and -2 mice. Normal mice could also show some symptoms of the disease after a treatment with Scl-GvHD, Bleomycin, or growth factor injection. Nevertheless, several observations made on these animal models are quite different than those ascertained in humans. Primary cultures of cells isolated from patients are also widely used, and, more recently, a new tissue-engineered reconstructed skin model was shown as a powerful tool to assess the mechanisms involved in the progression of human SSc.

Continue reading the full review article, by downloading it from the link provided below.

 
More articles :

» Thoracic Outlet Syndrome Secondary to Localized Scleroderma Treated With Botulinum Toxin Injection

Localized scleroderma is characterized by thickening of the skin and subcutaneous tissue. Depending on clinical and pathologic findings, localized scleroderma is classified into different subtypes: plaque morphea, generalized morphea, bullous...

» Making A Difference

, a Center for Student Missions team member, recently recounted a touching experience, in which she heard about and met someone with Scleroderma for the very first time. According to Jessica, "We don't always get to see the effect of what it is we...

» A Simple Blood Test Could Hold The Clue...

In a recent press release, the reported that a simple blood test could hold the clue and may even save lives. is a common condition, especially in teenagers, affecting approximately 10 million people in the UK. It can vary from being mild to very...

» A Scleroderma Fact Sheet

Below, is a very useful fact sheet on Scleroderma. Making for much easier reading and reference, this fact sheet highlights what Scleroderma is, how is it diagnosed, who gets it, complications which may arise, and how it can be treated. Feel free to...

» HRCT Useful In Sclerodermal Lung Disease Treatment

In a recent Reuters Health article, it was reported that the serial scanning of the thorax with (HRCT) is useful for monitoring the response of lung disease to therapy, according to a further report in the November .The report focused on 98...

» Jefferson Researchers Identify Mechanism Behind Fibrotic Disorder

Scientists from the of Thomas Jefferson University are now several steps closer to understanding the mechanism behind a novel systemic fibrotic disorder that affects some patients with renal insufficiency who receive imaging contrast agents for...